Clinical Study
Effects of a New Flavonoid and Myo-Inositol Supplement on Some Biomarkers of Cardiovascular Risk in Postmenopausal Women: A Randomized Trial
Table 1
Demographic and clinical characteristics of the study groups (mean ± SD).
| | NRT (basal) | Placebo (basal) | | NRT (6 months) | Placebo (6 months) | |
| Age (years) | 56.3 ± 3.8 | 55.5 ± 4.8 | 0.3 | | | | Menopause (months) | 95.1 ± 61.6 | 75.6 ± 57 | 0.2 | | | | BMI (Kg/m²) | 31.9 ± 3.8 | 33.6 ± 3.9 | 0.1 | 30.7 ± 3.9 | 33.3 ± 3.3 | 0.2 | Systolic blood pressure (mmHg) | 123.6 ± 12 | 132.6 ± 20 | 0.09 | 124 ± 9.1 | 121.6 ± 9.8 | 0.3 | Diastolic blood pressure (mmHg) | 80 ± 8 | 81.5 ± 11.9 | 0.3 | 73.6 ± 11.2 | 70 ± 6.3 | 0.17 | Waist circumference (cm) | 98.6 ± 6.2 | 100.8 ± 12.6 | 0.2 | 98.8 ± 6 | 96.3 ± 6.9 | 0.17 |
|
|